Visions 2013
read

World Ophthalmology Congress 2014 - Tokyo, Japan
Be sure to register for the world's largest international ophthalmology conference―the World Ophthalmology Congress®―to be held from April 2-6, 2014 in Tokyo, Japan. Simply click here to learn more and register to visit this global ophthalmology congress during the most beautiful time of year in Tokyo. What's more, if you sign up before October 18, 2013, you can take advantage of our special Early Bird fees! read

18th Retina International Worldconference in Paris, France
27th, 28th  and 29th June 2014 in Paris (France) presents ophthalmologists, scientists and patients with a unique  opportunity to learn about the latest developments in basic science and clinical trials for inherited retinal degenerative diseases (RP, Usher syndrome, Stargardt etc.) and AMD. read

iMove an iPhone app that supports visually impaired persons to move in urban environments
Retina Italia Onlus commissioned EveryWare Technologies to develop iMove, an iPhone app that supports visually impaired persons to autonomously move in urban environments. Thanks to iMove, an iPhone is now capable of reading the current address and the nearby shops. Moreover, it is possible to create audio notes, that are played every time a user gets close to a given place. iMove is a free app that is distributed world-wide through the App Store (https://itunes.apple.com/app/imove/id593874954). read

Recommendations for Genetic Testing of Inherited Eye Diseases
Report of the American Academy of Ophthalmology Task Force on Genetic Testing read

DRUGSFORD" consortium "Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration" successfully started!
The DRUGSFORD" consortium started successfully its work on the "Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration", co-ordinated by Dr. Francois Paquet-Durand. The total value of the consortium award is EURO4,971,428. read

FDA Panel Votes In Favor Of Retinal Prosthesis System Argus2
FDA advisory panel recommends that the federal watchdog agency approve a humanitarian device exemption for Second Sight's Argus II "bionic eye" retinal implant. read

New research suggests proinsulin administration may reduce vision loss in retinitis pigmentosa models
Novel research from the University of Alicante, Spain has suggested that the administration of proinsulin may be capable of slowing retinal degeneration and vision loss in a model of retinitis pigmentosa. read

Regeneron announces FDA approval for anti-VEGF Eylea to treat macular edema following CRVO
Regenerom Pharmaceuticals Inc (REGN, Tarrytown, New York) have announced the receipt of FDA approval for their VEGF trap eye product for the treatment of macular edema following central retinal vein occlusion. read

We can make a difference!
Michael Griffith founded in 1984 Fighting Blindness Ireland in the view to find a cure for Retinitis pigmentosa. Please see how the partnership between patients and scientists lead the way from genetic research to gene therapy. read

World Retina Day 2012
Retina International joins with Organisations around the world to raise awareness of retinal dystrophies. read